TRUPCR® ALL PCR Panel Kit
The TRUPCR® ALL PCR panel is intended for the qualitative detection of diagnostic and prognostic markers of acute lymphoblastic leukaemia (ALL) in peripheral blood samples using Real-time PCR system.
The TRUPCR® ALL PCR panel is intended for the qualitative detection of diagnostic and prognostic markers of acute lymphoblastic leukaemia (ALL) in peripheral blood samples using Real-time PCR system.
The TRUPCR® AML Panel Kit is intended for the qualitative detection of diagnostic and prognostic markers of acute myelogenous leukaemia (AML) in peripheral blood samples on conventional and Real-time PCR.
The TRUPCR® MPN Panel Kit is intended for the qualitative detection of JAK2-V617F, CALR, MPL W515K/L mutations and BCR-ABL1 translocation in Myeloproliferative neoplasms (MPNs) in peripheral blood samples using Real-time PCR.
The TRUPCR Paediatric Leukaemia Panel Kit is intended for the qualitative detection of 18 markers of paediatric leukaemia in peripheral blood samples using Real-time PCR.
The TRUPCR® C-KIT Mutation Detection is a PCR-based in vitro diagnostic test designed to detect D816V in the C-KIT gene in genomic DNA extracted from peripheral blood of patients diagnosed with acute myelogenous leukaemia (AML) or other malignancy.
The TRUPCR® CALR Kit is qualitative assay for the detection of CALR mutations in genomic DNA from whole blood of subjects suspected of myeloproliferative neoplasms (MPN).
The TRUPCR® FLT3 Mutation Detection is a PCR-based in vitro diagnostic test designed to detect internal tandem duplications (ITD) and tyrosine kinase domain (TKD) mutation (D835-I836) in the FLT3 gene in genomic DNA extracted from mononuclear cells obtained from peripheral blood of patients diagnosed with acute myelogenous leukaemia (AML).
The Nucleophosmin (NPM1) gene is one of the most commonly mutated genes in acute myeloid leukaemia (AML), occurring in about 35% of AML patients at diagnosis and in approximately 60% of adult cytogenetically normal AML (CN-AML).
TRUPCR® NPM1 Mutation Quantitative Kit is an in vitro nucleic acid amplification assay for the qualitative detection and quantification of NPM1 mutant allelic burden in clinical samples.
TRUPCR® JAK2 Kit (V2.0) is a Real-time PCR assay for qualitative detection of V617F mutation in JAK2 (Janus Kinase 2) gene against a background of wild-type genomic DNA.
TRUPCR JAK-2 allele burden kit is a Real-time PCR assay for quantification V617F mutation in JAK-2 (Janus Kinase 2) gene against a background of wild-type genomic DNA.
Detection of the PML-RARA t(15;17) translocation is diagnostic for acute promyelocytic leukaemia (APL), although the diagnosis can also be based on morphology.
TRUPCR® PML-RARA is an in vitro nucleic acid amplification assay for the qualitative and quantitative detection of PML/RAR-alpha fusion transcripts in human clinical samples.
Chronic myeloid leukaemia (CML) is characterized by the consistent involvement of the Philadelphia chromosome (Ph) and the BCR-ABL fusion gene, which derives from the reciprocal translocation t(9;22)(q34;q11) between chromosome 9 and 22.
TRUPCR® BCR-ABL QT kit is a RT-qPCR test for the quantitative detection of BCR-ABL fusion transcripts in bone marrow or peripheral blood samples.
The BCR-ABL1 Detection Kit is intended for the qualitative detection of BCR-ABL1 fusion gene (Major-BCR, minor-BCR, and micro -BCR) in bone marrow or peripheral blood samples using Real-time PCR.
TRUPCR® BCR-ABL1 Transcript Screening Kit is a RT-qPCR test for the detection and differentiation of BCR-ABL fusion transcripts in bone marrow or peripheral blood samples.
The TRUPCR® EGFR PCR Kit is an in vitro diagnostic test intended for the qualitative detection of EGFR somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® KRAS PCR Kit (K-RAS Kit) is an in vitro diagnostic test intended for the qualitative detection of KRAS somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® MGMT Methylation Detection Kit is intended to detect methylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter which predicts its response to alkylating agent (TMZ) in patients with glioblastoma.
The TRUPCR® BRAF Mutation Kit is an in vitro diagnostic test intended for the qualitative detection of BRAF somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® NRAS Mutation Kit is an in vitro diagnostic test intended for the qualitative detection of NRAS somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® ROS1 Gene Fusions Detection Kit is intended for the qualitative detection of 14 ROS1 gene fusions in human NSCLC formalin-fixed paraffin- embedded (FFPE) tissue samples using real time PCR system.
With an experienced team and innovative products, TRUPCR Europe supplies high quality qPCR molecular diagnostic products throughout Europe.
We offer technical support and training on all our products and are committed to increasing the efficiency of laboratory testing and enhancing patient care.
Unit 6, Williams House, Lloyd Street
North, Manchester Science Park,
Manchester M15 6SE
General enquires: info@trupcr.com
Technical support: techsupport@trupcr.com
Sales: sales@trupcr.com
Orders: orders@trupcr.com
Tel: +44 (0) 161 943 4731